10 /100
LOW RISK
Score updated May 29, 2026

XERS — Xeris Biopharma Holdings, Inc. Dilution Risk Tracker

Track XERS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track XERS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for XERS.
🔔 Track XERS — Get forecast alerts →

💹 Market Data

Market Cap$1.09B
Shares Outstanding172.64M
Float163.84M
Cash$111.75M
Debt$258.55M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 3.8% shares (2025Q4 vs prior)
228 institutional holders · 103.52M shares
#1 BlackRock, Inc. 12.64M shares
#2 VANGUARD GROUP INC 11.19M shares
#3 D. E. Shaw & Co., Inc. 7.57M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest15.89M
Days to Cover12.7
% of Float9.7%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jan 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track XERS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking XERS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for XERS
📊 XERS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 XERS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.